Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted naphthyridine and quinoline compounds as MAO inhibitors

Substituted naphthyridine and quinoline compounds as MAO inhibitors

US Patent 9956213 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Crystalline forms of a menin inhibitor2025
Chiral synthesis of a tertiary alcohol2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Isoquinolin-3-yl carboxamides and preparation and use thereof2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof2024
Substituted cyclohexyl compounds as NOP inhibitors2024
Substituted cyclohexyl compounds as NOP inhibitors2024